Lifetime risk Factors for pre- and post-bronchodilator lung function decline. a population-based study.
File(s)White-201904-329OC_Main text-Clean.docx (304.68 KB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Rationale: Interactions between early life and adult insults on lung function decline are not well understood, with most studies investigating prebronchodilator (pre-BD) FEV1 decline.Objectives: To investigate relationships between adult risk factors and pre- and post-BD lung function decline and their potential effect modification by early life and genetic factors.Methods: Multiple regression was used to examine associations between adult exposures (asthma, smoking, occupational exposures, traffic pollution, and obesity) and decline in both pre- and post-BD spirometry (forced expiratory volume in 1 s [FEV1], forced vital capacity [FVC], and FEV1/FVC) between ages 45 and 53 years in the Tasmanian Longitudinal Health Study (n = 857). Effect modification of these relationships by childhood respiratory risk factors, including low childhood lung function and GST (glutathione S-transferase) gene polymorphisms, was investigated.Results: Baseline asthma, smoking, occupational exposure to vapors/gases/dusts/fumes, and living close to traffic were associated with accelerated decline in both pre- and post-BD FEV1. These factors were also associated with FEV1/FVC decline. Occupational exposure to aromatic solvents was associated with pre-BD but not post-BD FEV1 decline. Maternal smoking accentuated the effect of personal smoking on pre- and post-BD FEV1 decline. Lower childhood lung function and having the GSTM1 null allele accentuated the effect of occupational exposure to vapors/gases/dusts/fumes and personal smoking on post-BD FEV1 decline. Incident obesity was associated with accelerated decline in FEV1 and more pronounced in FVC.Conclusions: This study provides new evidence for accentuation of individual susceptibility to adult risk factors by low childhood lung function, GSTM1 genotype, and maternal smoking.
Date Issued
2020-03
Date Acceptance
2019-12-03
Citation
Annals of the American Thoracic Society, 2020, 17 (3), pp.302-312
ISSN
1546-3222
Publisher
American Thoracic Society
Start Page
302
End Page
312
Journal / Book Title
Annals of the American Thoracic Society
Volume
17
Issue
3
Copyright Statement
© 2020 by the American Thoracic Society
Sponsor
Commission of the European Communities
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/31800292
Grant Number
633212
Subjects
bronchodilator
decline
interaction
lung function
susceptibility
Publication Status
Published
Coverage Spatial
United States
Date Publish Online
2020-03